Option chain shows key data for Anteris Technologies's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Anteris Technologies.

Anteris Technologies (NASDAQ:AVR) Stock, Option Chain

Anteris Technologies Glb

Anteris Technologies Global Corp. is a structural heart company committed to discovering, developing and commercializing medical devices designed to improve the quality of life for patients with aortic stenosis. Its product, the DurAVR THV system, represents a product opportunity in a new THV class of single-piece heart valves, for the treatment of aortic stenosis. Its DurAVR THV system consists of a single-piece, biomimetic valve made with its proprietary ADAPT tissue-enhancing technology and deployed with its ComASUR balloon-expandable delivery system. ADAPT is its proprietary anti-calcification tissue shaping technology that is designed to reengineer xenograft tissue into a pure, single-piece collagen bioscaffold.

Anteris Structural Heart PMS White

Equities

News

Markets

Movers

General

Barclays analyst initiates Positive coverage on Anteris Technologies, forecasting a 4%-5% U.S. TAVR market share for DurAVR by 2030.





Anteris Technologies Positioned To Capture 4%-5% Of US Transcatheter Valve Replacement Market By 2030: Analyst

Coca-Cola: A Reliable Dividend Stock

Initiation

Pre-Market Outlook

Analyst Ratings

Trading Ideas

ASND

ICLR

This Coca-Cola Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

Events

EDWARDS INTUITY Valve System Receives CE Mark

Anteris Technologies Global Corp. - Common Stock

Anteris Technologies Global Corp.

Avantis Real Estate ETF

Averox Inc

AVARONE METALS INC ORD by Avarone Metals Inc

Avarone Metals Inc

AVENIR WELLNESS SOLUTION by Avenir Wellness Solutions Inc.

Avenir Wellness Solutions Inc

Press Releases

Anteris Technologies Global Corp. Announces Closing of $88.8 Million U.S. Initial Public Offering

Anteris to Present at Healthcare Investor Conferences - TD Cowen and Barclays

Earnings

Anteris Reports 2024 Financial Results and Provides Corporate Update

Health Care

Anteris Reports One-Year Patient Outcomes for DurAVR® THV

Anteris Technologies Reaches Clinical Milestone: 100 patients treated with DurAVR® THV

Accuray

Anteris Technologies

Baird Medical Investment Holdings Ltd - Ordinary Share

Baird Medical Investment

BrainsWay Ltd. - American Depositary Shares

BrainsWay

CVRx

Alpha Tau Medical

Electromed

Inogen

Kewaunee Scientific Corporation - Common Stock

Kewaunee Scientific

KORU Medical Systems, Inc. - Common Stock

KORU Medical Systems

LENSAR

Lucid Diagnostics

Pulmonx

Microbot Medical

Monogram Technologies Inc. - Common Stock

Monogram Technologies

Myomo

Orchestra BioMed Holdings, Inc. - Ordinary Shares

Orchestra BioMed Hldgs

Outset Medical

Pro-Dex

ReShape Lifesciences, Inc. - Common Stock

Reshape Lifesciences

Sight Sciences

SANUWAVE Health

Stereotaxis

Tactile Systems Technology, Inc. - Common Stock

Tactile Systems Tech

ZimVie

JIN MEDICAL INTERNATIONAL LTD. - Ordinary Shares

Jin Medical International

Lake Street

TD Cowen

Cantor Fitzgerald

Barclays

Comments

Anteris Technologies

Anteris Technologies (AVR) Options

No option chain data available. Please try again later

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell